Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02171078 · ClinicalTrials.gov registry record
Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 34,359
- Enrollment target
NCT02171078 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 34,359 participants.
The verdict
NCT02171078 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 34,359 participants
- Enrollment target
Study Summary
Nearly three million living women have survived breast cancer. Physicians rely on clinical practice guidelines to make decisions on follow-up care. Among other things, the goal is to monitor for recurrence or side effects of treatment among survivors. It is unclear whether these guidelines represent the best approach for any given patient as they do not account for differences in disease or patient preferences and may not consider recent advances in imaging and treatment options. We seek to develop a new approach to surveillance following breast cancer treatment which will be more patient-centered and effective than the existing one-size-fits-all approach and will consider individual risk factors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34,359 participants |
| Start Date | 2014-06 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02171078
The ClinicalTrials.gov registry entry for NCT02171078 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34,359 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02171078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02171078 about?
NCT02171078 is a clinical study titled "Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance". Nearly three million living women have survived breast cancer. Physicians rely on clinical practice guidelines to make decisions on follow-up care. Among other things, the goal is to monitor for recurrence or side effects of treatment among survivors. It is unclear whether these guidelines represent...
What is the current status of trial NCT02171078?
This trial is currently completed. The enrollment target is 34,359 participants. The study started on 2014-06. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT02171078?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.